Open Calls for Input and Feedback


Listed are current opportunities for patient groups, clinician groups, drug plans, and cancer agencies to provide input or feedback on drugs being assessed within the reimbursement review process.

At CADTH, input is information, insight, or advice given to CADTH to contribute to a review. Feedback is a response to a prepared proposal, review report, or draft recommendation.

Draft Recommendations

tebentafusp (Kimmtrak)

Therapeutic Area: unresectable or metastatic uveal melanoma
Draft recommendations posted for stakeholder feedback:December 01
End of feedback period: December 15, 2022
Draft Recommendation

Submit Feedback

 

darolutamide (Nubeqa)

Therapeutic Area: Metastatic castration-sensitive prostate cancer
Draft recommendations posted for stakeholder feedback:December 01, 2022
End of feedback period: December 15, 2022
Draft Recommendation

Submit Feedback

 

pembrolizumab (Keytruda)

Therapeutic Area: Triple-negative breast cancer
Draft recommendations posted for stakeholder feedback:December 01, 2022
End of feedback period: December 15, 2022
Draft Recommendation

Submit Feedback

 

edaravone (Radicava)

Therapeutic Area: Amyotrophic lateral sclerosis
Draft recommendations posted for stakeholder feedback:November 24, 2022
End of feedback period: December 08, 2022
Draft Recommendation

Submit Feedback

 

Open Calls for Patient and Clinician Input

Therapeutic Area
Therapeutic Area: Relapsed or refractory follicular lymphoma
Call For Patient Input:
Call For Patient Input:
Patient Input Closed
Patient Input Closed:
Therapeutic Area
Therapeutic Area: unresectable hepatocellular carcinoma
Call For Patient Input:
Call For Patient Input:
Patient Input Closed
Patient Input Closed:
Therapeutic Area
Therapeutic Area: unresectable or metastatic HER2-low breast cancer
Call For Patient Input:
Call For Patient Input:
Patient Input Closed
Patient Input Closed:
Therapeutic Area
Therapeutic Area: Parkinson’s disease
Call For Patient Input:
Call For Patient Input:
Patient Input Closed
Patient Input Closed: